Viewing Study NCT05411133


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-02-28 @ 6:27 AM
Study NCT ID: NCT05411133
Status: RECRUITING
Last Update Posted: 2025-09-04
First Post: 2022-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Sponsor: Arbele Pty Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module